Lv592
1140 积分 2025-06-12 加入
The Elusive Horizon: Biomarkers in Urothelial Carcinoma
16天前
已完结
Clinical Implementation of Urinary Biomarkers for Surveillance of Non–muscle-invasive Bladder Cancer (NMIBC): Considerations from the European Association of Urology NMIBC Guideline Panel
17天前
已完结
Development of point-of-care tests for urinary bladder cancer – an historic review and view to future prospectives
21天前
已完结
Emerging technologies and clinical translation of urine-based liquid biopsy in urological cancers
22天前
已完结
Urinary bladder cancer needs more attention — recommendations for health care professionals and politicians in the European Union
24天前
已完结
Interobserver variability in cytopathology: How much do we agree?
1个月前
已完结
Impact of the 2022 Paris System on diagnostic accuracy and estimating the risk of high-grade malignancy in urine cytology
1个月前
已完结
Adequacy of voided urine specimens evaluated using the Paris system for reporting urine cytology
1个月前
已完结
Circulating tumour DNA and circulating tumour cells in bladder cancer — from discovery to clinical implementation
1个月前
已完结
Molecular biomarkers of progression in non-muscle-invasive bladder cancer — beyond conventional risk stratification
1个月前
已完结
皖公网安备34019202002308
